Zhang, Yun
Friedrich-Alexander-Universität Erlangen-Nürnberg · Universitätsklinikum Erlangen
3 papers on CoChatORCID 0000-0002-3004-9935
Most cited papers
- Verified
Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis
Huang, J., Beyer, C., Palumbo-Zerr, K., Zhang, Y., Ramming, A., Distler, A., Gelse, K., Distler, O., Schett, G., Wollin, L., et al. (2016) · Annals of the Rheumatic Diseases
Systemic Sclerosis and Related DiseasesDupuytren's Contracture and Treatments
Cited by 196
- Verified
Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosis
Zhang, Y., Dees, C., Beyer, C., Lin, N.-Y., Distler, A., Zerr, P., Palumbo, K., Susok, L., Kreuter, A., Distler, O., et al. (2015) · Annals of the Rheumatic Diseases
Systemic Sclerosis and Related DiseasesTGF-β signaling in diseases
Cited by 64
- Verified
The histone demethylase Jumonji domain-containing protein 3 (JMJD3) regulates fibroblast activation in systemic sclerosis
Bergmann, C., Brandt, A., Merlevede, B., Hallenberger, L., Dees, C., Wohlfahrt, T., Pötter, S., Zhang, Y., Chen, C.-W., Mallano, T., et al. (2018) · Annals of the Rheumatic Diseases
Systemic Sclerosis and Related DiseasesTGF-β signaling in diseases
Cited by 62
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free